BioDelivery Sciences to Present at Two Upcoming Investor Conferences

Rhea-AI Summary

BioDelivery Sciences International (NASDAQ: BDSI) announced that Jeffrey Bailey, Interim CEO, and CFO Terry Coelho will present at two investor conferences in June 2020. The Jefferies Virtual Healthcare Conference is scheduled for June 2 at 3:00 PM ET, followed by the William Blair 40th Annual Growth Stock Conference on June 11 at 9:40 AM ET. Attendees can access the webcasts for both events via provided links. A replay will be available on the company's website for 60 days. BDSI focuses on therapies for chronic conditions, including pain management and opioid dependence.

AI-generated analysis. Not financial advice.

News Market Reaction – BDSI

-0.21%

1 alert

-0.21% News Effect

On the day this news was published, BDSI declined 0.21%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

RALEIGH, N.C., May 29, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that Jeffrey Bailey, Interim Chief Executive Officer, and Terry Coelho, Chief Financial Officer, will present at two upcoming investor conferences in June. The management team will also host one-on-one investor meetings at the conferences.

Presentation Details:

Event: Jefferies Virtual Healthcare Conference
Date: Tuesday, June 2, 2020
Time: 3:00pm Eastern Time
Webcast: http://wsw.com/webcast/jeff126/bdsi/  

Event: William Blair 40^th Annual Growth Stock Conference
Date: Thursday, June 11, 2020
Time: 8:40am Central Time / 9:40am Eastern Time
Webcast: http://www.wsw.com/webcast/blair56/bdsi/

A replay of the presentations will be archived on the Company's website and made available for 60 days.
             
ABOUT BIODELIVERY SCIENCES INTERNATIONAL, INC.

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain, opioid dependence, and opioid-induced constipation.

© 2020 BioDelivery Sciences International, Inc.  All rights reserved.

Contact:

Terry Coelho
Chief Financial Officer
BDSI_IR@bdsi.com 

Bob Yedid
LifeSci Advisors
(646) 597-6989
bob@lifesciadvisors.com 

FAQ

What events will BDSI present at in June 2020?

BDSI will present at the Jefferies Virtual Healthcare Conference on June 2, 2020, and the William Blair 40th Annual Growth Stock Conference on June 11, 2020.

What time is BDSI's presentation at the Jefferies Virtual Healthcare Conference?

BDSI's presentation at the Jefferies Virtual Healthcare Conference is scheduled for June 2, 2020, at 3:00 PM Eastern Time.

What are the webcasts for the BDSI presentations?

The webcasts for the BDSI presentations can be accessed at http://wsw.com/webcast/jeff126/bdsi/ for Jefferies and http://www.wsw.com/webcast/blair56/bdsi/ for William Blair.

How long will the replays of BDSI's presentations be available?

Replays of BDSI's presentations will be available for 60 days on the company’s website.

What is BDSI's focus in the pharmaceutical market?

BDSI focuses on developing therapies for serious and complex chronic conditions, including pain management and opioid dependence.